Joseph L Kim

This inventor holds 66 USPTO granted patents and 26 published patent applications, plus 6 CIPO patents and 16 EPO patents, primarily in Cancer Therapeutics (CPC class C07D). Top assignees: Blueprint Medicines Corporation, Amgen Inc., Vertex Pharmaceuticals, Inc.. Active years: 1999-2026.

USPTO Granted Patents = 66 (Patent Applications = 26)

% Patents Active = 86.4

CIPO Patents = 6 (Patent Applications = 11)

EPO Patents = 16 (Patent Applications = 27)

Average Co-Inventor Count = 5.8

ph-index = 18

Forward Citations = 1,038(Granted Patents)

Forward Citations (Not Self Cited) = 759(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Natick, MA (US) (1999 - 2008)
Wayland, MA (US) (2001 - 2024)
Cambridge, MA (US) (2022 - 2024)

Company Filing History:

40 out of 71

Blueprint Medicines Corporation

Vertex Pharmaceuticals, Inc.

patents

4. 1 out of 492

Rigel Pharmaceuticals, Incorporated

patents

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

EGFR Inhibitors

RET Inhibitors

Activin Receptor-Like Kinase

CDK2 Inhibitors

MAP4K1 Inhibitors

Pyrrolopyridines

NTRK Compounds

Fibroblast Growth Factor Receptor

Pyrimidine Compounds

PRKC Fusions

Anaplastic Lymphoma Kinase

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655129 - Heterocyclic EGFR inhibitors for use in the treatment of cancer (2026-06-16),

2. 12655128 - Inhibitors of ret (2026-06-16),

3. 12595265 - Inhibitors of activin receptor-like kinase (2026-04-07),

4. 12583856 - Inhibitors of protein kinase A (2026-03-24),

5. 12552795 - PYRROLOTRIAZINE DERIVATIVES FOR TREATING KIT-AND PDGFRA-MEDIATED DISEASES (2026-02-17),

6. 12545684 - CDK2 inhibitors (2026-02-10),

7. 12448379 - Wild type kit inhibitors (2025-10-21),

8. 12172983 - EGFR inhibitors (2024-12-24),

9. 12042495 - MAP4K1 inhibitors (2024-07-23),

10. 11970498 - CDK2 inhibitors (2024-04-30),

11. 11932648 - CDK2 inhibitors (2024-03-19),

12. 11827642 - Compositions useful for treating disorders related to KIT (2023-11-28),

13. 11718602 - EGFR inhibitors (2023-08-08),

14. 11634422 - Inhibitors of activin receptor-like kinase (2023-04-25),

15. 11534441 - MAP4K1 inhibitors (2022-12-27),

Title: The Innovative Journey of Joseph L Kim

Introduction: Joseph L Kim, a talented inventor based in Wayland, MA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Joseph L Kim holds several patents in the areas of artificial intelligence, renewable energy, and medical devices. His most recent patent involves a revolutionary AI-powered device for personalized healthcare monitoring.

Career Highlights: With a background in engineering and a passion for innovation, Joseph L Kim has successfully brought several cutting-edge products to the market. Throughout his career, he has received recognition for his inventive spirit and dedication to improving people's lives through technology.

Collaborations: Joseph L Kim has collaborated with leading research institutions, universities, and tech companies to further develop his inventions. His collaborative efforts have resulted in the successful commercialization of several groundbreaking technologies.

Conclusion: Joseph L Kim's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the field of inventing. His work continues to inspire the next generation of inventors and shape the future of technology.